Forum Financial Management LP boosted its holdings in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 4.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,055 shares of the company’s stock after purchasing an additional 211 shares during the period. Forum Financial Management LP’s holdings in Colgate-Palmolive were worth $460,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CL. Brighton Jones LLC lifted its position in Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares during the period. GAMMA Investing LLC increased its holdings in shares of Colgate-Palmolive by 14.2% during the 1st quarter. GAMMA Investing LLC now owns 11,797 shares of the company’s stock valued at $1,105,000 after purchasing an additional 1,468 shares in the last quarter. Golden State Wealth Management LLC lifted its stake in shares of Colgate-Palmolive by 266.9% in the 1st quarter. Golden State Wealth Management LLC now owns 521 shares of the company’s stock valued at $49,000 after purchasing an additional 379 shares during the period. Sequoia Financial Advisors LLC boosted its holdings in Colgate-Palmolive by 1.0% during the first quarter. Sequoia Financial Advisors LLC now owns 25,535 shares of the company’s stock worth $2,393,000 after buying an additional 249 shares in the last quarter. Finally, PDS Planning Inc boosted its holdings in Colgate-Palmolive by 16.1% during the first quarter. PDS Planning Inc now owns 3,229 shares of the company’s stock worth $303,000 after buying an additional 448 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
CL has been the topic of several recent analyst reports. Citigroup lowered their target price on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research note on Monday, August 4th. Bank of America lowered their target price on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Barclays lowered their target price on shares of Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 1st. The Goldman Sachs Group lowered their target price on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research note on Thursday, October 2nd. Finally, Piper Sandler initiated coverage on shares of Colgate-Palmolive in a research note on Friday, October 3rd. They set a “neutral” rating and a $84.00 target price on the stock. Eight research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average price target of $91.50.
Colgate-Palmolive Stock Down 0.6%
CL stock opened at $78.01 on Friday. The stock has a market capitalization of $63.05 billion, a P/E ratio of 21.91, a P/E/G ratio of 4.58 and a beta of 0.34. The firm has a 50-day simple moving average of $81.33 and a 200-day simple moving average of $86.93. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 52 week low of $76.68 and a 52 week high of $100.18.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. The business had revenue of $5.11 billion during the quarter, compared to analysts’ expectations of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company’s quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.91 earnings per share. Equities analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio is currently 58.43%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- What is the Nikkei 225 index?
- Tractor Supply Stock Looks Like a Buy-and-Hold Winner
- Profitably Trade Stocks at 52-Week Highs
- 3 Stocks Well Below 52-Week Highs Poised for a Q4 Rebound
- Do ETFs Pay Dividends? What You Need to Know
- Big Banks Are Setting the Tone as Earnings Season Kicks Off
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
